VR Logo

Kilitch Drugs (India) Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1992

Chairman: --

Managing Director: Mukund P Mehta

Group: --

Listing: NSE: KILITCH, BSE: 524500

Headquarters: Thane, Maharashtra

Website: www.kilitch.com

Key Facts

Market cap: R 151.46 Cr

Revenue (TTM): R 61.02 Cr

Earnings (TTM): R 2.59 Cr

Cash: R 36.36 Cr

Total Debt: R 9.45 Cr

Promoters' ownership: 68.90%

Liquidity: Moderate

52 Week range: R 61.00 - 178.20

Face value: R10.00

Shares outstanding: 1,54,79,073

10 Years Aggregate:

  • CFO: -12.37 Cr
  • EBITDA: 55.65 Cr
  • Net Profit: 90.61 Cr

Stock Performance

Time Period Kilitch Drugs (I) S&P BSE Healthcare S&P BSE Small Cap
YTD-21.7317.93-15.54
1 month-4.483.294.22
3 months-3.5613.75-15.99
1 Year-41.5517.97-22.54
3 Years22.004.50-8.90
5 Years29.79-0.111.33
10 Years0.8211.122.98
As on 03-Jun-2020
Year Kilitch Drugs (I) S&P BSE Small Cap S&P BSE Healthcare
2019-21.07-6.85-3.55
201882.01-23.41-5.89
2017136.5459.640.49
2016-19.931.77-12.88
201516.756.7615.06
201463.9769.2447.43
2013-34.43-11.2322.55